Research Analysts Offer Predictions for Rani Therapeutics Holdings, Inc.'s FY2023 Earnings (NASDAQ:RANI)

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2023 earnings per share (EPS) estimates for Rani Therapeutics in a research note issued on Monday, July 10th. Cantor Fitzgerald analyst O. Brayer expects that the company will earn ($1.58) per share for the year. Cantor Fitzgerald has a […]

Related Keywords

United States ,America , ,Susquehanna International Group ,Renaissance Technologies ,America Corp ,Nasdaq ,Cantor Fitzgerald ,Rani Therapeutics Holdings Inc ,Icon Wealth Partners ,Rani Therapeutics Holdings ,Free Report ,Rani Therapeutics ,Rani Therapeutic ,Get Free Report ,International Group ,Therapeutics Holdings ,Rani Therapeutics Daily ,Nasdaq Rani ,Rani ,Medical ,Earnings Estimates ,